An Educational Resource by
Women's Cancer Initiative - Tata Memorial Hospital
21st June 2020
Indian Experience of Novel Formulation of Docetaxel
Speaker : Ghanashyam Biswas
Afatinib Versus Methotrexate as Second-Line Treatment in Asian Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Progressing on or After Platinum-Based Therapy (LUX-Head & Neck 3): An Open-Label, Randomised Phase III Trial
Speaker : Sandeep Goyle
Value of diffusion MR imaging in differentiation of recurrent head and neck malignancies from post treatment changes
Speaker : Ankush Jajodia
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Speaker : Rakesh Pinninti
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral Cancer
Speaker : Vijay Patil
Palliative chemotherapy with or without cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck: Indian tertiary care retrospective analysis
Speaker : Ankur Bahl
Panel discussion By Sevanti Limaye
Speaker : Sewanti Limaye
Platinum-based Regimens Versus Cetuximab in Definitive Chemoradiation for Human Papillomavirus-Unrelated Head and Neck Cancer
Speaker : Nandani Menon
Head-and-neck paragangliomas: An overview of 54 cases operated at a tertiary care center
Speaker : Rakesh Katna
Long-term outcomes of locally advanced and borderline resectable esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation treated with neoadjuvant chemotherapy.
Speaker : Ashay Karpe
Panel Discussion
Speaker : Adwaita Gore
Long-term Opioid Dependence after Radiation Therapy in Head/Neck Cancer Patients: A Retrospective Assessment of Incidence and Risk Factors.
Speaker : Pooja Nandawani
Orbital outcomes after orbit-sparing surgery and free flap reconstruction
Speaker : U S Vishal Rao
Late toxicities among laryngopharyngeal cancers patients treated with different schedules of concurrent chemoradiation at a rural tertiary cancer care center
Speaker : Geetha Muttath
Biomarkers in head and neck cancers - key publications rapid review
Speaker : Vanita Norohna
Status and strategies for the management of head and neck cancer during COVID ?19 pandemic: Indian scenario
Moderator : Vikram Kekatpure